Evidence map›Paper›PMID 42388921›Full record

ReviewCureus2026

Gastrointestinal Tract Polyp Detection, Tracking, and Surveillance and the Role of Artificial Intelligence.

John Azizian, Bhaskar Banerjee, Oleh Haluszka, Rolando Leal

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John AzizianGastroenterology and Hepatology, University of Arizona College of Medicine - Tucson, Tucson, USA.
Bhaskar BanerjeeGastroenterology and Hepatology, University of Arizona College of Medicine - Tucson, Tucson, USA.
Oleh HaluszkaGastroenterology and Hepatology, University of Arizona College of Medicine - Tucson, Tucson, USA.
Rolando LealGastroenterology and Hepatology, University of Arizona College of Medicine - Tucson, Tucson, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer remains a common malignancy and a leading cause of cancer-related mortality in the United States. Colonoscopy is widely utilized for screening, with the goal of early detection of malignancy, as well as identification and removal of pre-cancerous lesions. Screening strategies are guided by individual risk factors, including family history, the presence of hereditary conditions associated with increased colorectal cancer risk, and findings from prior colonoscopic examinations, including polyp number, size, and histologic characteristics. These factors inform recommendations on the appropriate timing for initiation and surveillance intervals. Endoscopic resection is generally preferred for the removal of adenomatous polyps when feasible, while more advanced lesions may require surgical intervention or specialized endoscopic techniques. Despite advances in technique and operator experience, lesions may still be missed during colonoscopy. To address this limitation and increase the yield of colonoscopies detecting lesions, artificial intelligence (AI)-based tools have been increasingly incorporated to enhance polyp detection and improve overall procedural quality. These technologies aim to support endoscopists in identifying subtle lesions, thus increasing malignancy and polyp detection rates, and thereby potentially contributing to more effective colorectal cancer prevention, lowering healthcare costs, and ultimately improving overall patient outcomes.

Indexed as

adenomaartificial intelligence (ai)colonoscopycolorectal canceresophagogastroduodenoscopy (egd)polypscreeningsurveillance

Identifiers

PMID42388921
PMCPMC13322772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.